• SENSEX 73,694.89
    448.86 (+0.61%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,380.50 1,356.40(%)
  • Reliance Industries
    1,182.00 1,611.20(%)
  • PTC Industries
    24,750.00 26,049.95(%)
  • NSE
    1,795.00 1,878.00(%)
  • Dalmia BharatLtd
    1,403.50 1,464.85(%)
  • Aeroflex
    579.00 613.50(%)
  • Pidilite Inds.
    1,429.05 1,707.95(%)
  • The Bombay Burmah
    1,176.50 1,108.20(%)
  • Billionbrains
    189.10 112.02(%)
  • Cholaman.Inv.&Fn
    1,589.95 1,952.00(%)
  • Bajaj Finance
    931.35 1,177.60(%)
  • Birlasoft Ltd
    351.50 473.75(%)
  • Max Healthcare
    865.95 1,196.50(%)
  • M & M Fin. Serv.
    256.60 253.30(%)
  • Coromandel Inter
    1,734.65 2,496.10(%)
  • Adani Ports
    1,857.35 1,891.80(%)
  • JSW Dulux
    286.50 374.67(%)
  • Tube Investments
    2,098.60 2,006.00(%)
  • Acutaas Chemical
    4,000.00 3,977.00(%)
  • Moneyview
    52.44 65.43(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Caplin Point Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4464.0
  • ISIN : INE475E01026
2,362.80 10 (0.44%)
  • As on 29 Oct 2026 (EOD)

  • Today’s Low

    2,330.00

  • Today’s High

    2,377.10

  • Open

    2,352.00

  • Perv Close

    2,352.40

  • 52W Low

    1,500.30

  • 52W High

    2,990.00

Key Indicators

  • P/E(TTM)

    42.78

  • Mar.Cap (₹Cr.)

    17,960.04

  • Div & Yield %

    0.34

  • Book Value(₹)

    269.76

  • Debt-Equity Ratio

    0.44

  • AGM Date

    28-Oct-2026

  • EPS

    55.22

  • P/E Ratio

    42.78

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    17,960.04

  • RONW (%)

    24.52

  • ROCE (%)

    26.67

Score Board

  • Equity (₹ in Cr.)

    15.20

  • BV (₹)

    269.80

  • Sales( ₹ in Cr.)

    738.33

  • NP (in Cr.)

    383.29

  • NP Var(%)

    13.0

  • Div%

    400.0

  • CPS (₹)

    53.80

  • EPS (₹)

    50.40

  • Traded Value (₹ in Lakhs)

    17,958.14

  • 52 Week High

    2,990.00

  • 52 Week Low

    1,500.30

  • Price BSE

    2363.0

  • Price NSE

    2,363.00

  • Market Capital( in Cr.)

    17,958.14

  • P/C Ratio

    43.90

  • P/E Ratio

    46.90

  • Price Vs.BV

    50.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 738.33 752.41 625.09 528.61 528.06 482.68
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 738.33 752.41 625.09 528.61 528.06 482.68
Other Income 195.37 134.59 105.84 99.00 56.55 18.62
Stock Adjustments 12.37 -24.36 43.68 1.67 9.00 0.57
Total Income 946.07 862.64 774.61 629.28 593.61 501.87
EXPENDITURE :            
Raw Materials 241.33 213.81 248.90 199.73 213.65 195.40
Power and Fuel Cost 13.64 14.11 15.43 9.89 9.54 6.36
Employee Cost 47.72 52.13 38.11 36.68 30.47 26.59
Other Manufacturing Expenses 27.05 24.00 25.43 13.73 10.81 7.75
Selling and Administration Expenses 65.81 75.50 40.75 40.30 43.51 28.12
Miscellaneous Expenses 17.37 16.53 13.07 10.03 9.46 5.10
Employee Benefit Expenses 47.72 52.13 38.11 36.68 30.47 26.59
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 412.92 396.08 381.69 310.36 317.44 269.32
Operating Profit 533.15 466.56 392.92 318.92 276.17 232.55
Interest 0.20 0.12 0.10 0.12 0.09 0.17
Gross Profit 532.95 466.44 392.82 318.80 276.08 232.38
Depreciation 25.43 24.77 27.08 25.65 25.77 22.44
Profit Before Tax 507.52 441.67 365.74 293.15 250.31 209.94
Current Tax 109.49 102.90 86.12 66.58 61.62 54.88
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.45 -0.72 -4.09 -7.69 0.82 -1.17
Reported Net Profit 396.58 339.49 283.71 234.26 187.87 156.23
Extraordinary Items 13.29 -0.33 1.19 1.17 0.75 4.67
Adjusted Net Profit 383.29 339.82 282.52 233.09 187.12 151.56
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,634.99 1,333.49 1,083.95 880.01 714.84 561.64
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 45.61 37.99 34.17 30.32 22.70 3.03
P & L Balance carried down 1,985.96 1,634.99 1,333.49 1,083.95 880.01 714.84
Dividend 22.81 18.99 15.19 15.16 11.35 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 400.00 300.00 250.00 225.00 200.00 150.00
Dividend Per Share(Rs) 8.00 6.00 5.00 4.50 4.00 3.00
Earnings Per Share-Unit Curr 52.18 44.67 37.35 30.86 24.78 20.65
Earnings Per Share(Adj)-Unit Curr 52.18 44.67 37.35 30.86 24.78 20.65
Book Value 269.80 223.81 183.03 150.19 122.78 100.29
Book Value(Adj)-Unit Curr 269.80 223.81 183.03 150.19 122.78 100.29

Shareholding Pattern

  • Promoter Group

    70.57%

  • Public Share Holding

    29.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,637,000 3.47 2,637,000 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 51,005,353 67.10 51,005,353 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 53,642,353 70.57 53,642,353 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1 0.00 1 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3,550 0.00 3,550 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,354,006 5.73 4,354,006 157
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 60,226 0.08 60,226 8
Mutual Funds / UTI 1,243,828 1.64 1,243,828 20
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 363,032 0.48 363,032 15
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 6,024,643 7.93 6,024,643 203
2] Non Institution
Bodies Corporate 1,223,292 1.61 1,222,792 753
Clearing Members 60 0.00 60 2
Directors of their Relatives 7,000 0.01 7,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,036,349 1.36 1,031,349 3,325
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 341,713 0.45 341,713 1,530
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 902,135 1.19 902,135 5
Individuals holding nominal share capital up to Rs. 1 lakh 10,455,727 13.76 9,930,102 97,545
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 13,507 0.02 13,507 9
Others 2,304,402 3.03 2,254,402 5
Sub Total 16,344,700 21.50 15,763,575 103,176
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 76,011,696 100.00 75,430,571 103,386

Company Background

Caplin Point Laboratories LtdPharmaceuticals - Indian - Formulations

  • Caplin Point Laboratories Ltd
  • BSE Code : 4464.0
  • ISIN : INE475E01026

  • Incorporation Year

    1990

  • Registered Office

    Ashvich Towers 3rd Floor
    No 3 Developed Plots Ind Estat, Chennai,
    Tamil Nadu-600096

  • Telephone

    91-44-24968000/71148000/28156653

  • FAX

    91-44-28154952

  • Chairman

    C C Paarthipan

  • Managing Director

    Sridhar Ganesan

  • Company Secretary

  • Auditor

    Brahmayya & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Integrated Registry Mgt Ser.Pv
    2nd Floor Kences Tow,
    1 Ramakrishna Street,Usman Road T.Nagar
    Mumbai - Chennai-600017

Caplin Point Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Caplin Point Lab 2,362.55 933.70 738.33 42.78 26.98
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77